Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
70 search results
Will the rapid development of COVID-19 vaccines lead to unsafe therapies?
Why the UK can hold its head high in the drive for pharma innovation.
Additive manufacturing is so much more than just “cool” technology; it holds great promise for the biopharma industry.
Platinum group (and other precious) metal catalysts are inherently expensive, so why not recover and recycle?
How can artificial intelligence improve access to novel therapeutics?
How can we effectively manage the treatment of type 1 diabetes?
We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.
From LIMS to AI, connected technologies are becoming a strategic initiative for an increasing number of smart companies.
When following COVID-19 research, it’s hard to keep your eye on the ball...
QC must evolve to meet progress in biopharmaceutical manufacturing.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.